Search | Pikumil

Akash Motar added blog Other
2025-12-16 13:04:58 -

Muckle Wells Syndrome Market: Orphan Drug Development, Targeted Biologics and JAK Inhibitors, and Gene Therapy Advancements
"Detailed Analysis of Executive Summary Muckle Wells Syndrome Market Size and Share Data Bridge Market Research analyzes that the global muckle wells syndrome market which was USD 12.80 billion in 2022, is likely to reach USD 25.48 billion by 2030, and is expected to undergo a CAGR of 4.1% during the forecast period 2023 to 2030. The Muckle Wells Syndrome report makes available the current and...

0 Comments 0 Shares 572 Views 0 Reviews

Please log in to like, share and comment!
John Werizon added blog Other
2026-03-10 08:28:15 -

Rare Inherited Metabolic Disorder Drug Market to Benefit from Growing Orphan Drug Approvals
Rare diseases often sit quietly in the background of global healthcare discussions, yet they affect millions of people worldwide. Among them, rare inherited metabolic disorders (IMDs) represent a complex group of genetic conditions that disrupt the body’s metabolism. Although each disorder may affect only a small number of individuals, collectively they form a significant...

0 Comments 0 Shares 70 Views 0 Reviews

Please log in to like, share and comment!
Akash Motar added blog Other
2025-12-17 14:53:10 -

Short Bowel Syndrome Drugs Market: GLP-2 Analog Pipeline, Parenteral Nutrition Reduction Strategies, and Orphan Drug Development Trends
"Market Trends Shaping Executive Summary Short Bowel Syndrome Drugs Market Size and Share Data Bridge Market Research analyses a growth rate in the global short bowel syndrome drugs market in the forecast period 2022-2029. The expected CAGR of global short bowel syndrome drugs market is tend to be around 15% in the mentioned forecast period. The market was valued at USD 1.44 billion in 2021,...

0 Comments 0 Shares 539 Views 0 Reviews

Please log in to like, share and comment!
Ajay Sukla added blog Health
2026-04-06 12:50:46 -

Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%
According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...

0 Comments 0 Shares 78 Views 0 Reviews

Please log in to like, share and comment!